Skip to content

Changes in Plasma Osmolality Related to the Use of Cardiopulmonary Bypass With Hyperosmolar Prime.

Changes in Plasma Osmolality Related to the Use of Cardiopulmonary Bypass With Hyperosmolar Prime, an Observational Study.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03060824
Enrollment
30
Registered
2017-02-23
Start date
2017-02-21
Completion date
2017-12-11
Last updated
2017-12-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiopulmonary Bypass

Keywords

Osmolality, Sodium, CABG, Cardiovascular Diseases, Cardiopulmonary bypass

Brief summary

During the use of Cardiopulmonary Bypass (CPB) for cardiac surgery there is an instant mixture of the patient's blood and the fluid needed to fill the extracorporeal circuit before use. This will change the composition of the body fluids. This study aims to plot these changes in regard to particle concentration (osmolality).

Detailed description

During the use of CPB for cardiac surgery there is an instant mixture of the patient's blood and the fluid needed to prime the extracorporeal circuit. Many studies have pointed to the benefits of using a hyperosmolar prime to counteract formation of tissue oedema. Rapid changes in osmolality may as a serious consequence lead to osmotic demyelination syndrome. At the Heart Centre of Umeå University Hospital, Sweden, there is a tradition of using a hyperosmolar prime. This study aims to explore changes in osmolality during coronary artery bypass grafting surgery by repeated measurements of osmolality and concentration shifts of sodium, glucose and urea in plasma.

Interventions

OTHERBlood sampling

To explore changes in osmolality during coronary artery bypass grafting surgery with the aid of Cardiopulmonary Bypass by repeated measurements of osmolality and concentration shifts of sodium, glucose and urea in plasma.

Sponsors

Umeå University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Age 60-80 yr * New York Heart Association Functional Classification(NYHA) I-III * Body Surface Area(BSA) 1.8-2.5 m2

Exclusion criteria

* Diabetes * Estimated Glomerular Filtration Rate(eGFR)\<50ml/min/1,73 m2

Design outcomes

Primary

MeasureTime frameDescription
Changes in plasma osmolalityBefore surgery; repeated during surgery and on postoperative day 1 and 2.Repeated measurements of plasma osmolality aim to outline changes in plasma osmolality related to the use of hyperosmolar prime.

Secondary

MeasureTime frameDescription
Change in osmolar gapBefore surgery; repeated during surgery and on postoperative day 1 and 2.Analysing urea, sodium and glucose in plasma using the same sampling intervals as for plasma osmolality enables calculation of the osmolar gap and to set its relation to the use of hyperosmolar prime

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026